Vesikari, T., Matson, D.O., Dennehy, P., Van Damme, P., Santosham, M., Rodriguez, Z., et al., for The Rotavirus Efficacy Safety Trial (REST) Study Team (2006) Safety and Efficacy of Pentavalent Human-Bovine (WC3) Reassortant Rotavirus Vaccine in Preventing Rotavirus Gastroenteritis and Reducing Associated Health Care Resource Utilization. The New England Journal of Medicine, 354, 23-33.
https://doi.org/10.1056/NEJMoa052664

has been cited by the following article:

• TITLE: Molecular Characterization of Rotavirus Strains Circulating in Enugu Nigeria: 2011 to 2016

  AUTHORS: B. N. Tagbo, C. Chukwubike, J. M. Mwenda, M. L. Seheri, G. Armah, J. M. Mphahlele, U. C. Ozumba, C. Benjamin-Puja, C. Azubuike, H. U. Okafor, R. O. Nnani, V. Okafor, B. O. Edelu, C. B. Eke, O. Udemba, A. Isiaka, L. Namadi, N. Umezinne, R. Njoku, C. Odume, V. Osaro, N. Ogude, M. U. Okwesili, S. K. Ezebilo, K. M. Yusuf, E. O. Obidike, ICH UNTH Enugu Rotavirus Group

  KEYWORDS: Rotavirus, Molecular Characterization, Children, Genotype

  JOURNAL NAME: World Journal of Vaccines, Vol.9 No.1, February 20, 2019

  ABSTRACT: Rotavirus gastroenteritis is a major public health concern globally, estimated to cause 215,000 deaths among children